Hefty Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$76K Hold
1,196
0.05% 124
2017
Q4
$73K Hold
1,196
0.05% 122
2017
Q3
$76K Hold
1,196
0.05% 115
2017
Q2
$66K Hold
1,196
0.05% 114
2017
Q1
$65K Hold
1,196
0.05% 113
2016
Q4
$69K Hold
1,196
0.06% 98
2016
Q3
$64K Buy
1,196
+1,109
+1,275% +$71.2K 0.05% 112
2016
Q2
$6K Hold
87
0.01% 161
2016
Q1
$5K Hold
87
﹤0.01% 166
2015
Q4
$5K Buy
+87
New +$5.75K ﹤0.01% 160

Other funds holding BMY

Hefty Wealth Partners's BMY Position: Q1 2018 in Review

Hefty Wealth Partners held its Bristol-Myers Squibb (BMY) position steady in Q1 2018 at 1,196 shares worth $76K. The position accounts for 0.05% of the portfolio, ranked #124.

Hefty Wealth Partners first reported a position in BMY in Q4 2015 and has held it in 10 quarters since. 1,747 funds tracked by Wall St. Rank hold BMY as of Q1 2018.

  • Hefty Wealth Partners held 1,196 shares of Bristol-Myers Squibb worth $76K as of Q1 2018.
  • Hefty Wealth Partners left its Bristol-Myers Squibb share count unchanged in Q1 2018.
  • Bristol-Myers Squibb made up 0.05% of Hefty Wealth Partners's portfolio in Q1 2018, its #124 holding.
  • Hefty Wealth Partners first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 10 quarters since.
  • 1,747 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2018.

Based on Hefty Wealth Partners's 13F filing for Q1 2018, filed 2 Apr 2018.